ESC 365 - Role of non-HDL as the target for lipid management in secondary prevention and its relation to clinical events.

EAPC Premium Access

Role of non-HDL as the target for lipid management in secondary prevention and its relation to clinical events.

Session: Poster Session II - Friday 08:30 - 18:00 - Diabetes/ Lipids/Obesity/Nutrition_Part 2

Topic: Lipids

Speaker: Doctor L. Alvarez Roy (Zaragoza, ES)

Event: EuroPrevent 2017

Congress Presentation

About the speaker

Doctor Laura Alvarez Roy

UNIVERSITY HOSPITAL MIGUEL SERVET, Zaragoza (Spain)

0 follower

12 more presentations in this session

Diabetes/ Lipids/Obesity/Nutrition_Part 2 - Poster discussant:.

Atrial fibrillation preventive effect of n-3 polyunsaturated fatty acids in patients with hypertension

Speaker: Doctor S. Okamoto (Tsu, Mie, JP)

High rate of achievement of target values in LDL-cholesterol reduction through cardiac rehabilitation in patients with acute coronary syndrome

Speaker: Professor B. Schwaab (Timmendorfer Strand, DE)

Predictors of non-coronary aterosclerosis progression one year after coronary surgery

Speaker: Professor O. Barbarash (Kemerovo, RU)

Benefit of the PCSK9 inhibitor evolocumab in patients undergoing lipid apheresis

Access the full session

Poster Session II - Friday 08:30 - 18:00 - Diabetes/ Lipids/Obesity/Nutrition_Part 2

Speakers: Doctor L. Alvarez Roy, Doctor S. Okamoto, Professor B. Schwaab, Professor O. Barbarash

About the event

EuroPrevent 2017

6 April - 8 April 2017

Sessions Presentations

Congress

ESC 365 is supported by